Table 3 Cardiac SPECT and CT findings
From: Diagnostic performance of hybrid cardiac SPECT/CT imaging for patients with takotsubo cardiomyopathy
TC (n = 11) | ACS (n = 11) | P value | |
|---|---|---|---|
Cardiac SPECT | |||
SMDS | 5 (3–7) | 8 (4–16) | 0.216 |
A-MDS | 3 (2–6) | 3 (1–7) | 0.567 |
NA-MDS | 0 (0–2) | 5 (3–7) | 0.022 |
SBDS | 10 (8–12) | 18 (9–24) | 0.354 |
A-BDS | 8 (5–11) | 7 (2–10) | 0.386 |
NA-BDS | 0 (0–5) | 9 (6–13) | 0.022 |
SMS | 5 (3–7) | 6 (3–8) | 0.531 |
A-MS | 3 (2–6) | 1 (1–3) | 0.136 |
NA-MS | 0 (0–2) | 3 (2–6) | 0.080 |
ECG-gated cardiac SPECT | |||
LVEF (%) | 69 (54–74) | 62 (43–71) | 0.503 |
LVEDV (ml) | 69 (62–83) | 93 (58–119) | 0.497 |
LVESV (ml) | 23 (16–39) | 35 (20–65) | 0.460 |
A-%WT | 48 (32–56) | 48 (27–57) | 0.546 |
NA-%WT | 39 (28–45) | 28 (21–44) | 0.302 |
Cardiac CT | |||
CAD (none/1VD/2VD/3VD) | 7/2/1/1 | 5/3/1/2 | 0.900 |
LAD stenosis | 3 (27%) | 3 (27%) | 1.000 |
Dx stenosis | 1 (9%) | 3 (27%) | 0.586 |
LCX stenosis | 1 (9%) | 5 (45%) | 0.149 |
RCA stenosis | 2 (18%) | 3 (36%) | 1.000 |